Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Squamous-cell carcinoma of the tongue following therapy of rheumatoid arthritis with abatacept.

Deidda A, Pisanu C, Garau D, Longu MG, Moretti MD, Sanna ME, Moretti GM, Stochino ME.

Clin Case Rep. 2014 Jun;2(3):66-9. doi: 10.1002/ccr3.56. Epub 2014 Mar 13.

2.

Variations of somatotype in elderly Sardinians.

Buffa R, Succa V, Garau D, Marini E, Floris G.

Am J Hum Biol. 2005 Jul-Aug;17(4):403-11.

PMID:
15981180
3.

Antimicrobial evaluation of coumarins and flavonoids from the stems of Daphne gnidium L.

Cottiglia F, Loy G, Garau D, Floris C, Casu M, Pompei R, Bonsignore L.

Phytomedicine. 2001 Jul;8(4):302-5.

PMID:
11515721
4.

Chemical composition and cytotoxic and antimicrobial activity of Calycotome villosa (Poiret) link leaves.

Loy G, Cottiglia F, Garau D, Deidda D, Pompei R, Bonsignore L.

Farmaco. 2001 May-Jul;56(5-7):433-6.

PMID:
11482772
5.

Liposome-incorporated santolina insularis essential oil: preparation, characterization and in vitro antiviral activity.

Valenti D, De Logu A, Loy G, Sinico C, Bonsignore L, Cottiglia F, Garau D, Fadda AM.

J Liposome Res. 2001;11(1):73-90. doi: 10.1081/LPR-100103171.

PMID:
19530920
6.

Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells.

Rizzo MT, Regazzi E, Garau D, Akard L, Dugan M, Boswell HS, Rizzoli V, Carlo-Stella C.

Cancer Res. 1999 Oct 1;59(19):5047-53.

7.

Clonogenic potential and phenotypic analysis of CD34+ cells mobilized by different chemotherapy regimens.

Cesana C, Regazzi E, Garau D, Caramatti C, Mangoni L, Rizzoli V.

Haematologica. 1999 Sep;84(9):771-8.

8.

Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cells.

Carlo-Stella C, Regazzi E, Sammarelli G, Colla S, Garau D, Gazit A, Savoldo B, Cilloni D, Tabilio A, Levitzki A, Rizzoli V.

Blood. 1999 Jun 1;93(11):3973-82.

PMID:
10339507
9.

Primitive hematopoietic progenitors within mobilized blood are spared by uncontrolled rate freezing.

Cilloni D, Garau D, Regazzi E, Sammarelli G, Savoldo B, Caramatti C, Mangoni L, Rizzoli V, Carlo-Stella C.

Bone Marrow Transplant. 1999 Mar;23(5):497-503.

10.

CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.

Cesana C, Carlo-Stella C, Regazzi E, Garau D, Sammarelli G, Caramatti C, Tabilio A, Mangoni L, Rizzoli V.

Bone Marrow Transplant. 1998 Mar;21(6):561-8.

11.

The parallel between CD45 expression and extra-medullary evolution in aggressive myeloma with high serum lactate dehydrogenase.

Cesana C, Giachetti R, Almici C, Garau D, Mangoni L, Pesci A, Carlo-Stella C.

Haematologica. 1998 Mar;83(3):276-9. No abstract available.

12.

Reverse transcription polymerase chain reaction is a reliable assay for detecting leukemic colonies generated by chronic myelogenous leukemia cells.

Savoldo B, Sammarelli G, Dotti G, Garau D, Regazzi E, Cilloni D, Tabilio A, Rizzoli V, Carlo-Stella C.

Leukemia. 1998 Mar;12(3):434-40.

13.

Biologic and phenotypic analysis of early hematopoietic progenitor cells in umbilical cord blood.

Almici C, Carlo-Stella C, Wagner JE, Mangoni L, Garau D, Rizzoli V.

Leukemia. 1997 Dec;11(12):2143-9.

14.

Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.

Carlo-Stella C, Tabilio A, Regazzi E, Garau D, La Tagliata R, Trasarti S, Andrizzi C, Vignetti M, Meloni G.

Bone Marrow Transplant. 1997 Sep;20(6):465-71.

15.

Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation.

Almici C, Carlo-Stella C, Wagner JE, Mangoni L, Garau D, Re A, Giachetti R, Cesana C, Rizzoli V.

Bone Marrow Transplant. 1997 Jun;19(11):1079-84.

16.

Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.

Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G.

Haematologica. 1997 May-Jun;82(3):291-6.

17.

Detection of breast cancer cells using the magnetic cell separation (MACS) system: implications for stem cell purging.

Garau D, Regazzi E, Savoldo B, Sammarelli G, Rizzoli V, Carlo-Stella C.

Eur J Histochem. 1997;41 Suppl 2:17-8. No abstract available.

PMID:
9859763
18.

In vitro growth of mobilized peripheral blood progenitor cells is significantly enhanced by stem cell factor.

Cesana C, Carlo-Stella C, Mangoni L, Regazzi E, Garau D, Sammarelli G, Caramatti C, Almici C, Rizzoli V.

Stem Cells. 1997;15(3):207-13.

19.

Assessment of the efficacy of a last-generation polyvalent immunoglobulin in the treatment of idiopathic thrombocytopenic purpura.

Pacetti P, Garau D, Caramatti C, Mangoni L, Zamboni V, Canova N, Rizzoli V.

Curr Med Res Opin. 1997;13(9):517-27.

PMID:
9169254
20.

Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein.

Carlo-Stella C, Dotti G, Mangoni L, Regazzi E, Garau D, Bonati A, Almici C, Sammarelli G, Savoldo B, Rizzo MT, Rizzoli V.

Blood. 1996 Oct 15;88(8):3091-100.

PMID:
8874208
21.

Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells.

Carlo-Stella C, Regazzi E, Garau D, Mangoni L, Rizzo MT, Bonati A, Dotti G, Almici C, Rizzoli V.

Br J Haematol. 1996 Jun;93(3):551-7.

PMID:
8652372
22.

BCL2 oncogene protein expression in human hematopoietic precursors during fetal life.

Bonati A, Albertini R, Garau D, Pinelli S, Lunghi P, Almici C, Carlo-Stella C, Rizzoli V, Dall'Aglio P.

Exp Hematol. 1996 Feb;24(3):459-65.

PMID:
8599976
23.

Density separation of umbilical cord blood and recovery of hemopoietic progenitor cells: implications for cord blood banking.

Almici C, Carlo-Stella C, Mangoni L, Garau D, Cottafavi L, Ventura A, Armanetti M, Wagner JE, Rizzoli V.

Stem Cells. 1995 Sep;13(5):533-40.

PMID:
8528103
24.

Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow.

Almici C, Manoni L, Carlo-Stella C, Garau D, Cottafavi L, Rizzoli V.

Bone Marrow Transplant. 1995 Jul;16(1):95-101.

PMID:
7581136
25.

[Evaluation of the effectiveness and tolerability of MED 15 vs. piroxicam in patients with acute epicondylitis].

Meloni P, Demuro G, Cara L, Garau D, Uras G, Suddu L.

Clin Ter. 1995 Jun-Jul;146(6-7):453-6. Italian.

PMID:
7586997
26.
27.

Selection of Philadelphia-negative progenitors from chronic myelogenous leukemia.

Carlo-Stella C, Mangoni L, Piovani G, Garau D, Dotti GP, Almici C, Rizzoli V.

Bone Marrow Transplant. 1994;14 Suppl 3:S45-8. No abstract available.

PMID:
7535153
28.

Biological and chemical selection of Ph-negative clones.

Carlo-Stella C, Mangoni L, Piovani G, Garau D, Almici C, Rizzoli V.

Stem Cells. 1993 Oct;11 Suppl 3:77-82.

PMID:
8298479
29.

Fractionation of chronic myelogenous leukemia marrow cells by stroma adherence: implications for marrow purging.

Rizzoli V, Mangoni L, Piovani G, Garau D, Caramatti C, Almici C, Carlo-Stella C.

Leuk Lymphoma. 1993;11 Suppl 1:109-12.

PMID:
8251884
30.

Autologous bone marrow transplantation for acute myeloid and lymphoid leukemia.

Rizzoli V, Carlo-Stella C, Almici C, Garau D, Carella AM, Coser P, Angrilli F, Bernabei PA, Mozzana R, Alessandrino E, et al.

Leukemia. 1992 Nov;6 Suppl 4:103-5. No abstract available.

PMID:
1434811
31.

Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.

Carlo-Stella C, Mangoni L, Almici C, Garau D, Craviotto L, Piovani G, Caramatti C, Rizzoli V.

Exp Hematol. 1992 Mar;20(3):328-33.

PMID:
1568448
32.

In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfamide and recombinant granulocyte--macrophage colony-stimulating factor.

Carlo-Stella C, Mangoni L, Piovani G, Almici C, Garau D, Caramatti C, Rizzoli V.

Bone Marrow Transplant. 1991 Oct;8(4):265-73.

PMID:
1756324

Supplemental Content

Support Center